Smith & Nephew plc (NYSE:SNN) Receives Average Rating of “Moderate Buy” from Analysts

Smith & Nephew plc (NYSE:SNNGet Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight research firms that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and five have issued a buy rating on the company.

A number of brokerages have weighed in on SNN. Barclays upgraded Smith & Nephew from an “underweight” rating to an “equal weight” rating in a report on Tuesday, November 28th. HSBC upgraded Smith & Nephew from a “hold” rating to a “buy” rating in a report on Tuesday, October 31st. Finally, JPMorgan Chase & Co. upgraded Smith & Nephew from a “neutral” rating to an “overweight” rating in a report on Friday, November 3rd.

Get Our Latest Stock Report on SNN

Smith & Nephew Trading Up 0.1 %

Smith & Nephew stock opened at $27.86 on Thursday. The company’s fifty day moving average price is $27.30 and its 200 day moving average price is $26.17. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.19 and a quick ratio of 0.83. Smith & Nephew has a 1 year low of $21.52 and a 1 year high of $33.08.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Bessemer Group Inc. raised its holdings in shares of Smith & Nephew by 397.3% during the 4th quarter. Bessemer Group Inc. now owns 920 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 735 shares during the period. CWM LLC raised its holdings in Smith & Nephew by 68.6% in the 4th quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 388 shares during the period. Spire Wealth Management raised its holdings in Smith & Nephew by 224.3% in the 4th quarter. Spire Wealth Management now owns 1,015 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 702 shares during the period. Allworth Financial LP raised its holdings in Smith & Nephew by 1,566.2% in the 3rd quarter. Allworth Financial LP now owns 1,133 shares of the medical equipment provider’s stock valued at $28,000 after buying an additional 1,065 shares during the period. Finally, EverSource Wealth Advisors LLC raised its holdings in Smith & Nephew by 75.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,227 shares of the medical equipment provider’s stock valued at $33,000 after buying an additional 526 shares during the period. Hedge funds and other institutional investors own 8.65% of the company’s stock.

About Smith & Nephew

(Get Free Report

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.

Further Reading

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.